Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CREBL2 |
| Upstream (Parents) |
|---|
| (<<) PPP1R16B → CREBL2 |
| (<<) GIMAP1 → CREBL2 |
| (<<) EVI2B///EVI2A → CREBL2 |
| Downstream (Children) |
|---|
| CREBL2 → GABARAPL3///GABARAPL1 (>>) |
| CREBL2 → SNHG3-RCC1///RCC1 (>>) |
| CREBL2 → LOC387723 (>>) |
| CREBL2 → SCNN1B (>>) |
| CREBL2 → NELL2 (>>) |
| CREBL2 → ABAT (>>) |
| CREBL2 → BCL2 (>>) |
| CREBL2 → VLDLR (>>) |
| CREBL2 → C2orf88 (>>) |
| CREBL2 → C13orf15 (>>) |
| CREBL2 → ARTN (>>) |
| CREBL2 → PLOD1 (>>) |
| CREBL2 → PITRM1 (>>) |
| CREBL2 → BARX1 (>>) |
| CREBL2 → ACVR2A (>>) |
| CREBL2 → TMEM220 (>>) |
| CREBL2 → NF2 (>>) |
| CREBL2 → SMS (>>) |
| CREBL2 → PVR (>>) |
